伊布利特治疗心律失常的电生理机制及临床应用进展

rial fibrillation or flutter[J]. Am J Health Syst Pharm, 2003, 60(22): 2308. [27]Patsilinakos S, Christou A, Kafkas N, et al. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent[J]. Am J Cardiol, 2010, 106(5): 673. [28]Korantzopoulos P, Letsas KP, Kotsia A, et al. Ibutilideand novel indexes of ventricular repolarization in persistent atrial fibrillation patients[J]. World J Cardiol, 2013, 5(7): 242. [29]Nair M, e LK, Koshy SK. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation[J]. J Am Board Fam Med, 2011, 24(1): 86. [30]李巧艳. 富马酸伊布利特治疗心律失常不良反应临床研究[J]. 中国社区医师, 2014(29): 24. (收稿日期:2015-08-13)(本文编辑:张岚)李泽霖,张玲,汤宝鹏. 伊布利特治疗心律失常的电生理机制及临床应用进展[J/CD]. 中华临床医师杂志:电子版,2016,10(5):680-683.